Breast cancer · BMC Med · 2026
The summary reports no severe hand-foot skin reactions. The paper’s own table: 5 of 26 patients.
Share of patients with hand-foot syndrome; severe means grade 3, the top level
The paper says
26 breast-cancer patients took two drugs, one in tiny fat bubbles meant to shield heart and skin. The summary reports no severe heart damage or hand-foot syndrome (a painful skin reaction on palms and soles); the paper says this early result supports the shielding idea.
Its own data show
The paper’s own table and results: 13 of 26 patients (50%) had hand-foot syndrome, and 5 (19.2%) had grade 3, the most severe level on the standard grading scale the paper uses. On the every-4-weeks schedule the paper recommends for the next phase of trials, 7 of 11 had it, 3 severely.
A paper’s summary is the short overview at the top; many readers, and many databases that index studies, read nothing else. This one contradicts the paper’s own table on a side effect that hit half the patients, and the paper cites that supposed absence as support for the bubbles sparing the skin. Nothing in the paper contradicts the heart claim.